Invention Grant
US09540618B2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
有权
用于产生由同型二聚体,同三聚体或二聚体二聚体和用途组成的稳定连接络合物的方法
- Patent Title: Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
- Patent Title (中): 用于产生由同型二聚体,同三聚体或二聚体二聚体和用途组成的稳定连接络合物的方法
-
Application No.: US14533857Application Date: 2014-11-05
-
Publication No.: US09540618B2Publication Date: 2017-01-10
- Inventor: Chien-Hsing Chang , David M. Goldenberg , William J. McBride , Edmund A. Rossi
- Applicant: IBC Pharmaceuticals, Inc.
- Applicant Address: US NJ Morris Plains
- Assignee: IBC Pharmaceuticals, Inc.
- Current Assignee: IBC Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Morris Plains
- Agent Richard A. Nakashima
- Main IPC: C07K19/00
- IPC: C07K19/00 ; C07K16/00 ; C07K16/28 ; C07K16/18 ; C12N9/12 ; B82Y5/00 ; B82Y10/00 ; C07K16/30

Abstract:
The present invention concerns methods and compositions for stably tethered structures of defined compositions, which may have multiple functionalities and/or binding specificities. Particular embodiments concern homodimers comprising monomers that contain a dimerization and docking domain attached to a precursor. The precursors may be virtually any molecule or structure, such as antibodies, antibody fragments, antibody analogs or mimetics, aptamers, binding peptides, fragments of binding proteins, known ligands for proteins or other molecules, enzymes, detectable labels or tags, therapeutic agents, toxins, pharmaceuticals, cytokines, interleukins, interferons, radioisotopes, proteins, peptides, peptide mimetics, polynucleotides, RNAi, oligosaccharides, natural or synthetic polymeric substances, nanoparticles, quantum dots, organic or inorganic compounds, etc. Other embodiments concern tetramers comprising a first and second homodimer, which may be identical or different. The disclosed methods and compositions provide a facile and general way to obtain homodimers, homotetramers and heterotetramers of virtually any functionality and/or binding specificity.
Public/Granted literature
Information query